Head-to-head comparison of in vitro and in vivo efficacy of pHLIP-conjugated anti-seed gamma peptide nucleic acids
Source abstract
Abstract
Gamma peptide nucleic acids (γPNAs) have recently garnered attention in diverse therapeutic and diagnostic applications. Serine and diethylene-glycol-containing γPNAs have been tested for numerous RNA-targeting purposes. Here, we comprehensively evaluated the in vitro and in vivo efficacy of pH-low insertion peptide (pHLIP)-conjugated serine and diethylene-based γPNAs. pHLIP targets only the acidic tumor microenvironment and not the normal cells. We synthesized and parallelly tested pHLIP-serine γPNAs and pHLIP-diethylene glycol γPNAs that target the seed region of microRNA-155, a microRNA that is upregulated in various cancers. We performed an all-atom molecular dynamics simulation-based computational study to elucidate the interaction of pHLIP-γPNA constructs with the lipid bilayer. We also determined the biodistribution and efficacy of the pHLIP constructs in the U2932-derived xenograft model. Overall, we established that the pHLIP-serine γPNAs show superior results in vivo compared with the pHLIP-diethylene glycol-based γPNA.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · DNA and Nucleic Acid Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (75)
Show source-provided references
1. MicroRNAs: target recognition and regulatory functions10.1016/j.cell.2009.01.002 ↗
2. The biological functions of miRNAs: lessons from in vivo studies10.1016/j.tcb.2014.11.004 ↗
3. A review of currently identified small molecule modulators of microRNA function10.1016/j.ejmech.2019.112008 ↗
4. MicroRNA sponges: progress and possibilities10.1261/rna.2414110 ↗
5. Anti-miRNA oligonucleotides: A comprehensive guide for design10.1080/15476286.2018.1445959 ↗
6. Inhibition of microRNA function by antimiR oligonucleotides10.1186/1758-907X-3-1 ↗
7. Small-molecule inhibitors of microrna miR-21 function10.1002/anie.200801555 ↗
8. A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype10.1016/j.chembiol.2021.07.006 ↗
9. Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit10.1021/jacs.6b11273 ↗
10. MicroRNA-133 controls cardiac hypertrophy10.1038/nm1582 ↗
11. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis10.1038/ni.1798 ↗
12. Transgenic microRNA inhibition with spatiotemporal specificity in intact organisms10.1038/nmeth.1402 ↗
13. Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs10.1016/j.cell.2010.03.039 ↗
14. Silencing of microRNAs in vivo with 'antagomirs'10.1038/nature04303 ↗
15. Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development10.3390/jcm9062004 ↗
16. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting10.1016/j.cmet.2006.01.005 ↗
17. LNA-mediated microRNA silencing in non-human primates10.1038/nature06783 ↗
18. Improved targeting of miRNA with antisense oligonucleotides10.1093/nar/gkl183 ↗
19. gamma Peptide Nucleic Acid-Based miR-122 Inhibition Rescues Vascular Endothelial Dysfunction in Mice Fed a High-Fat Diet10.1021/acs.jmedchem.1c01831 ↗
20. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide10.1126/science.1962210 ↗
21. The peptide nucleic acids (PNAs), powerful tools for molecular genetics and cytogenetics10.1038/sj.ejhg.5201226 ↗
22. A simple gamma-backbone modification preorganizes peptide nucleic acid into a helical structure10.1021/ja0625576 ↗
23. Synthesis and characterization of conformationally preorganized, (R)-diethylene glycol-containing gamma-peptide nucleic acids with superior hybridization properties and water solubility10.1021/jo200482d ↗
24. pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery10.1038/s41598-020-75443-5 ↗
25. Targeting diseased tissues by pHLIP insertion at low cell surface pH10.3389/fphys.2014.00097 ↗
26. Targeting Acidic Diseased Tissues by pH-Triggered Membrane-Associated Peptide Folding10.3389/fbioe.2020.00335 ↗
27. Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors10.1073/pnas.1715350115 ↗
28. Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation10.1158/1541-7786.MCR-19-0661 ↗
29. Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix10.1073/pnas.0601463103 ↗
30. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment10.1038/nature13905 ↗
31. Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles10.1016/j.jconrel.2020.08.026 ↗
32. Enzyme-Triggered Release of the Antisense Octaarginine-PNA Conjugate from Phospholipase A2 Sensitive Liposomes10.1021/acsabm.9b01022 ↗
33. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
34. Understanding and overcoming major barriers in cancer nanomedicine10.2217/nnm.10.23 ↗
35. Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?10.1021/acs.bioconjchem.6b00437 ↗
36. Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes10.1002/adhm.202202859 ↗
37. Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey10.1089/ard.1994.4.201 ↗
38. Integrated Safety Assessment of 2'-O-Methoxyethyl Chimeric Antisense Oligonucleotides in NonHuman Primates and Healthy Human Volunteers10.1038/mt.2016.136 ↗
39. Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 8810.1124/jpet.105.084004 ↗
40. Considerations for the Characterization and Interpretation of Results Related to Alternative Complement Activation in Monkeys Associated with Oligonucleotide-Based Therapeutics10.1089/nat.2015.0593 ↗
41. Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition10.2174/1566523214666140825154158 ↗
42. Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy10.1126/sciadv.abq7459 ↗
43. miR-155 as a diagnostic and prognostic marker in hematological and solid malignancies10.4149/neo_2014_032 ↗
44. Proliferation and Apoptosis of B-Cell Lymphoma Cells under Targeted Regulation of FOXO3 by miR-15510.4084/mjhid.2020.073 ↗
45. microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells10.3892/mmr.2012.779 ↗
46. Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy10.1158/0008-5472.CAN-21-0736 ↗
47. Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-110.3109/10428194.2012.659736 ↗
48. Modular self-assembly of gamma-modified peptide nucleic acids in organic solvent mixtures10.1038/s41467-020-16759-8 ↗
49. Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics10.1261/rna.079498.122 ↗
50. Targeting the Hypoxic and Acidic Tumor Microenvironment with pH-Sensitive Peptides10.3390/cells10030541 ↗
51. Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity10.1093/narcan/zcab021 ↗
52. Nanoparticle for delivery of antisense gammaPNA oligomers targeting CCR510.4161/adna.25628 ↗
53. Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy10.1021/acsami.1c11981 ↗
54. Next-generation poly-L-histidine formulations for miRNA mimic delivery10.1016/j.omtm.2023.03.015 ↗
55. Membrane binding and insertion of a pHLIP peptide studied by all-atom molecular dynamics simulations10.3390/ijms140714532 ↗
56. Focus on PNA Flexibility and RNA Binding using Molecular Dynamics and Metadynamics10.1038/srep42799 ↗
57. Secondary structure of cell-penetrating peptides controls membrane interaction and insertion10.1016/j.bbamem.2010.03.005 ↗
58. pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path10.1073/pnas.0914330107 ↗
59. A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers10.1529/biophysj.107.109967 ↗
60. Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide
61. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform10.1186/1758-2946-4-17 ↗
62. An Automated Force Field Topology Builder (ATB) and Repository: Version 1.010.1021/ct200196m ↗
63. Testing and validation of the Automated Topology Builder (ATB) version 2.0: prediction of hydration free enthalpies10.1007/s10822-014-9713-7 ↗
64. Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP)10.1073/pnas.2016605118 ↗
65. Molecular Dynamics Modeling Based Investigation of the Effect of Freezing Rate on Lysozyme Stability10.1007/s11095-022-03358-z ↗
66. GROMACS: fast, flexible, and free10.1002/jcc.20291 ↗
67. Interaction of an antimicrobial peptide with a model lipid bilayer using molecular dynamics simulation10.1021/la900365g ↗
68. Molecular dynamics studies of transportan 10 (tp10) interacting with a POPC lipid bilayer10.1021/jp107763b ↗
69. Interactions of Abeta25-35 beta-barrel-like oligomers with anionic lipid bilayer and resulting membrane leakage: an all-atom molecular dynamics study10.1021/jp107558e ↗
70. Effect of lipid composition on buforin II structure and membrane entry10.1002/prot.22074 ↗
71. Insights into buforin II membrane translocation from molecular dynamics simulations10.1016/j.peptides.2012.09.022 ↗
72. Lipid interaction and membrane perturbation of human islet amyloid polypeptide monomer and dimer by molecular dynamics simulations10.1371/journal.pone.0038191 ↗
73. Conformations of islet amyloid polypeptide monomers in a membrane environment: implications for fibril formation10.1371/journal.pone.0047150 ↗
74. Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature10.1016/S0006-3495(97)78845-3 ↗
75. Canonical dynamics: Equilibrium phase-space distributions10.1103/PhysRevA.31.1695 ↗